AFRM, ZNTL, IMTX, MRCY and DRRX have been added to the Zacks Rank #1 (Strong Buy) List on January 9, 2024.

Immatics N.V. IMTX shares are trading higher after the company announced a $35 million equity investment from Bristol-Myers Squibb Company BMY. Bristol Myers Squibb purchased 2.42 million ordinary shares in a private placement transaction at a subscription price per share of $14.46.

Immatics N.V. IMTX shares are shooting higher today after it revealed an interim clinical data update for 11 patients with recurrent and/or refractory solid cancers treated with ACTengine IMA203 TCR-T monotherapy in the ongoing Phase 1b dose expansion Cohort A.

U.S. stocks traded lower this morning even as the Federal Reserve's two-day meeting began. Following the market opening Tuesday, the Dow traded down 0.47% to 33,891.31 while the NASDAQ fell 0.12% to 12,197.84. The S&P 500 also declined, losing 0.37% to 4,152.34. Health care shares jumped by ...